{"slug":"pt-141-insomnia","verification":{"valid":true,"entries":2,"head":"8fd312dfb88a3bf2100ff33f59acc7f50677c761feaeca43353bb8f4053925d8"},"energy":{"passes":2,"tokens_in":15126,"tokens_out":2920,"tokens_total":18046,"cost_usd":0,"models":{"grok/grok-4.3":1,"owner":1},"head":"8fd312dfb88a3bf2100ff33f59acc7f50677c761feaeca43353bb8f4053925d8"},"provenance":[{"ts":"2026-06-30T01:14:09.941Z","model":"grok/grok-4.3","action":"write","prompt":"","input":"Write a data-first, evidence-graded article: PT 141 for Insomnia\nSlug: pt-141-insomnia\nAudience: readers researching peptide evidence for this specific condition or drug cross.\nRules: label every claim tier (human|preclinical|anecdotal|mechanistic|speculative). Separate human trials from rat studies from Reddit/X anecdotes. No medical claims. Repair-vs-suppression framing. register: source_ledger.\n\nENRICHMENT BRIEF (binding section logic — one ## per compound):\n{\"voice\":\"enrichment\",\"article_shape\":\"single_focus\",\"condition\":null,\"condition_key\":null,\"primary_peptide\":null,\"peptides_in_scope\":[{\"id\":\"pt-141\",\"name\":\"PT-141\"}],\"drugs_in_scope\":[],\"weight_sensitive\":false,\"stimulant_context\":false,\"breaking_down\":{\"section_title\":\"What's breaking down\",\"degenerative_why\":[],\"degenerative_layers\":[],\"note\":\"No condition profile matched — infer degeneration layers from slug/title and ledger claims.\"},\"peptide_chains\":[{\"peptide\":\"pt-141\",\"name\":\"PT-141\",\"section_title\":\"Why PT-141 might help you\",\"layer\":\"sexual / CNS arousal\",\"steps\":[\"**Therefore for you:** If that layer is part of your problem, PT-141 is discussed because it targets repair (tissue) — not because it masks pain.\"],\"prose\":\"1. **Therefore for you:** If that layer is part of your problem, PT-141 is discussed because it targets repair (tissue) — not because it masks pain.\"}],\"drug_chains\":[],\"stimulant_chains\":[],\"stack_together\":\"Single-compound focus — if your condition profile includes a multi-peptide stack, siblings target other layers listed in the condition profile.\\n- **PT-141** → sexual / CNS arousal\",\"section_headings\":[\"What's breaking down\",\"Why PT-141 might help you\",\"How these fit together\",\"What the evidence actually shows\",\"What scientists say\",\"What people say on Reddit\",\"What people say on X\",\"What we do not know\",\"Safety and limits\"],\"writer_rules\":[\"One ## section per compound in peptide_chains — do not merge into one peptide essay.\",\"Each Why section must use if-then steps from peptide","response":"{\n  \"slug\": \"pt-141-insomnia\",\n  \"title\": \"PT-141 for Insomnia: Evidence-Graded Review\",\n  \"body\": \"## What's breaking down\\nInsomnia involves disrupted sleep-wake regulation. The hypothalamus helps control both sexual arousal and sleep cycles through shared pathways. When CNS arousal signals stay elevated or misfire at night, falling or staying asleep becomes harder. No single peptide fixes this directly. Repair would mean restoring balanced signaling in those brain regions rather than forcing sedation.\\n\\n## Why PT-141 might help you\\nPT-141 activates melanocortin receptors (mainly MC4R) in the hypothalamus. This is the same area that processes both sexual motivation and aspects of arousal state.\\n\\n1. If your insomnia links to under-arousal or flattened motivation during the day that flips into nighttime restlessness, the CNS arousal layer is one possible contributor.\\n2. PT-141 is discussed for that layer because it engages central pathways rather than acting as a sedative or masking symptoms.\\n3. Therefore for you: If that layer is part of your problem, PT-141 is discussed because it targets repair (tissue/CNS signaling balance) — not because it masks pain or forces sleep.\\n\\nHuman data for insomnia itself does not exist. All clinical work focused on sexual desire.\\n\\n## How these fit together\\nSingle-compound focus. PT-141 targets the sexual / CNS arousal layer only. If your insomnia profile involves other layers (hormonal, inflammatory, or mechanical), additional compounds would address those separately.\\n\\n## What the evidence actually shows\\nNo randomized trials tested PT-141 for insomnia. Phase 3 RECONNECT trials (two identical studies, ~1,200+ premenopausal women) measured sexual desire and distress scores over 24 weeks. They showed statistically significant improvements in desire domain scores versus placebo but reported no sleep endpoints (source: pubmed.ncbi.nlm.nih.gov/31599840, clinicaltrials.gov NCT02338960 and NCT02333071).\\n\\nSide-effect data from","tokens_in":15126,"tokens_out":2920,"cost":0,"prev":"genesis","hash":"0258fe9c0761eac0dd3137cabfd3bcdf0127ee047cef11bbc6247fb2f1d224be"},{"ts":"2026-07-17T02:41:07.342Z","model":"owner","action":"voxel_divide","prompt":"","input":"pt-141-insomnia","response":"22 DIVs from body (verbatim, roundtrip-checked)","tokens_in":0,"tokens_out":0,"cost":0,"prev":"0258fe9c0761eac0dd3137cabfd3bcdf0127ee047cef11bbc6247fb2f1d224be","hash":"8fd312dfb88a3bf2100ff33f59acc7f50677c761feaeca43353bb8f4053925d8"}]}